Interventional Oncology - Theraputic Lesion Access (TLA) (image)
Interventional Oncology - Theraputic Lesion Access (TLA) (image)

TLA (Therapeutic Lesion Access)
Interventional Oncology

Our wide-ranging product lineup supports consistent and effective therapeutic lesion access in interventional oncology.
Contents
To top
Navigate Distally with Ease¹
Embolize with Reliability
Navigate Distally with Ease¹

Progreat™

Since first being sold in Japan in 2000, Terumo’s Progreat™ now supports physicians and patients around the world.
Progreat product (image)
Ease of Use
Coaxial system
Terumo's coaxial system allows fast and smooth procedures through wire integration and easy microcatheter preparation.
Kink Resistance
Tungsten spiral coil & three layer structure
The tungsten spiral coil in its three layer structure protects inner lumen integrity for smooth delivery of all types of embolic materials.2
Distal Flexibility
Mcoat™ & varied coil pitch
The varied pitch of the tungsten coil with Terumo's hydrophilic coating provides flexibility thus notably increasing its distal selectivity in tortuous and narrow vessels.2
Product line up
Wide range of diameters
Progreat™ comes in a range of diameters (2.8 Fr, 2.7 Fr, 2.4 Fr, 2.0 Fr) to better serve you and your patients. We also offer preloaded 2.4 Fr systems for greater selectivity and simpler preparation.
Product Information: Progreat™

Reference

 

  1. Progreat is considered as being reliable due to the kink resistance results obtained during bench testing2 and Prgreat is on the market for more than 15 years
  2. Bench testing done by Terumo Corporation. Data on file (TC-Pro107). Bench test data may not necessarily be indicative of clinical performance

Progreat λ™

Master Ultra Branch Selectivity
Progreat λ product (image)

Reference

 

  1. Bench testing performed by TERUMO CLINICAL SUPPLY CO., LTD.. Data on file (2020-NMC-020, 2020-NMC-021, 2020-NMC-022, 2020-NMC-027, 2020-NMC-030). Bench test result may not necessarily be indicative of clinical performance. Read and follow the manufacturer’s IFU to be used with this product.
  2. Lipiodol is a brand name of Guerbet. Progreat λ is intended for therapeutic embolization and angiography in peripheral vessels. Progreat λ is not available for sale in all countries. Please contact your Terumo local sales representative for more information.
Product Information: Progreat λ™

RADIFOCUS™ Guide Wire GT with gold coil

RADIFOCUS™ Guide Wire GT is Terumo’s solution for access and navigation in peripheral procedures. It is indicated for use in distal catheterization, selective, and superselective embolization in small, distal, angular, and sensitive peripheral vasculature.

  • Small diameters and distal pre-shaped curves for superselective access in distal and tortuous vessels.
  • The tapered tip is designed to be highly flexible for atraumatic and controlled navigation through vessels.
RADIFOCUS™ Guide Wire GT with gold coil (image)
Product Information: RADIFOCUS™ Guide Wire GT
Embolize with Reliability

Occlusafe™

Terumo Interventional Oncology Division presents Occlusafe™, an occlusive micro-balloon.

Through Pressure Gradient Effect, Occlusafe™ as micro-balloon catheter, offers the ability to redistribute blood flow and access the microcirculation, leading to an increased accumulation of therapeutics into the target lesion with minimal off-target embolization. This may be associated with improved clinical outcomes in challenging lesions.3

Occlusafe™ Product Introduction
Product Information: Occlusafe™

Learn more about the procedure

 

  1. Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloonoccluded Arterial Stump Pressure
  2. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
  3. Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching
  4. Initial Experience with Balloon-Occlusion Prostatic Artery Embolization